FI905702A - Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter. - Google Patents

Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter. Download PDF

Info

Publication number
FI905702A
FI905702A FI905702A FI905702A FI905702A FI 905702 A FI905702 A FI 905702A FI 905702 A FI905702 A FI 905702A FI 905702 A FI905702 A FI 905702A FI 905702 A FI905702 A FI 905702A
Authority
FI
Finland
Prior art keywords
dessa
tiazolylaettikssyraderivat
kumarinderivat
anvaendning
och
Prior art date
Application number
FI905702A
Other languages
English (en)
Finnish (fi)
Other versions
FI905702A0 (fi
Inventor
Eberhard Kuckert
Gunther Beck
Florin Seng
Antonius Loebberding
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19893938598 external-priority patent/DE3938598A1/de
Priority claimed from DE19904026613 external-priority patent/DE4026613A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI905702A0 publication Critical patent/FI905702A0/fi
Publication of FI905702A publication Critical patent/FI905702A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI905702A 1989-11-21 1990-11-19 Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter. FI905702A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19893938598 DE3938598A1 (de) 1989-11-21 1989-11-21 Optischer biosensor
DE19904026613 DE4026613A1 (de) 1990-08-23 1990-08-23 Cumarinderivate, verfahren zu ihrer herstellung, ihre verwendung und thiazolyl-essigsaeurederivate als zwischenprodukte

Publications (2)

Publication Number Publication Date
FI905702A0 FI905702A0 (fi) 1990-11-19
FI905702A true FI905702A (fi) 1991-05-22

Family

ID=25887279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905702A FI905702A (fi) 1989-11-21 1990-11-19 Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter.

Country Status (6)

Country Link
US (1) US5300656A (fr)
EP (1) EP0428939B1 (fr)
JP (1) JPH03176485A (fr)
CA (1) CA2030243A1 (fr)
DE (1) DE59010069D1 (fr)
FI (1) FI905702A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587472A (en) * 1991-08-13 1996-12-24 Bayer Corporation Coumarin-labeled nucleoside 5'-triphosphates
DE4302459A1 (de) * 1993-01-29 1994-08-04 Bayer Ag Sulfocumarinhaltige Nukleotide und deren Verwendung in Nachweisverfahren für Nukleinsäuren
EP1077695A2 (fr) * 1998-05-22 2001-02-28 Avanir Pharmaceuticals COMPOSES AYANT DES PROPRIETES AFFECTANT LES IgE
US6169185B1 (en) 1999-02-25 2001-01-02 Day-Glo Color Corp. Ink jet printing inks
WO2002008217A2 (fr) 2000-07-21 2002-01-31 Chugai Seiyaku Kabushiki Kaisha DERIVES DE LA COUMARINE UTILISES COMME INHIBITEUR DU TNF$g(a)
US9475901B2 (en) 2009-12-08 2016-10-25 Transitions Optical, Inc. Photoalignment materials having improved adhesion
WO2013101974A1 (fr) * 2011-12-30 2013-07-04 Ptc Therapeutics, Inc. Composés de traitement d'une amyotrophie spinale
EP3368927B1 (fr) 2015-10-30 2024-10-16 Transitions Optical, Inc. Article optique avec proprietes gradient de propriétés influencant la lumiere et son procédé de fabrication
EP3368926B1 (fr) 2015-10-30 2024-03-06 Transitions Optical Ltd. Procédé de réalisation d'un article optique avec système d'impression à jet d'encre

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE154402C (fr) *
US4146712A (en) * 1976-03-11 1979-03-27 Ciba-Geigy Corporation Process for the manufacture of coumarin dyes
CH620322B (de) * 1976-03-26 Ciba Geigy Ag Verwendung von 3-phenyl-7-(v-triazol-2-yl)-cumarinen zum optischen aufhellen von organischen materialien.
DE2807761A1 (de) * 1978-02-23 1979-08-30 Basf Ag Cumarinderivate
US4547579A (en) * 1978-10-10 1985-10-15 Ciba-Geigy Corporation Substituted benzopyran compounds
DE3064042D1 (en) * 1979-08-27 1983-08-11 Bayer Ag Light collector system and use of coumarin derivatives as energy converters in such systems
DE3001877A1 (de) * 1980-01-19 1981-07-23 Bayer Ag, 5090 Leverkusen Lichtsammelsysteme und die verwendung von cumarinderivaten als energiewandler in ihnen
DE3101141A1 (de) * 1981-01-16 1982-09-02 Bayer Ag, 5090 Leverkusen Triazolylcumarinverbindungen, sowie deren herstellung und verwendung als optiche aufheller, scintillatoren und laserfarbstoffe
DE3229301A1 (de) * 1982-08-05 1984-04-12 Bayer Ag, 5090 Leverkusen Heterocyclische verbindungen
DE3609804A1 (de) * 1986-03-22 1987-09-24 Basf Ag Thiazolyl-cyan-cumarine und ihre verwendung zur flaechenmaessigen konzentrierung von licht

Also Published As

Publication number Publication date
DE59010069D1 (de) 1996-02-29
CA2030243A1 (fr) 1991-05-22
JPH03176485A (ja) 1991-07-31
EP0428939B1 (fr) 1996-01-17
EP0428939A2 (fr) 1991-05-29
EP0428939A3 (en) 1992-03-25
FI905702A0 (fi) 1990-11-19
US5300656A (en) 1994-04-05

Similar Documents

Publication Publication Date Title
FI915387A (fi) Tuggummi, som avger smak under en foerlaengd tidsperiod och som innehaoller omaettade, renade monoglycerider.
FI885052A (fi) Katalysatorsystem, som foerhindrar bildning av svavelvaete och som innehaoller kopparoxid.
FI902248A0 (fi) N-heteroaryl-4-kinolinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI906139A (fi) Halogenerade olefiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som skadedjursbekaempningsmedel.
FI891222A (fi) Arylpiperazinylalkoxiderivat av cykliska imider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI891411A0 (fi) Neopentylesterderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI903214A0 (fi) Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.
FI905689A (fi) 3-aminopyrroler, foerfaranden foer deras framstaellning, och deras anvaendning som laekemedel.
FI904823A0 (fi) Karboxylsyraestrar, naemnda karboxylsyraestrar innehaollande flytande kompositioner och foerfaranden foer smoerjning av metalldelar.
FI914556A0 (fi) 4- eller 5-substituerade pyridiner-2-karboxylsyror, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI905702A0 (fi) Kumarinderivat, foerfarande foer framstaellning av dessa, anvaendning av dessa och tiazolylaettikssyraderivat som mellanprodukter.
FI904660A0 (fi) Som fungicider anvaendbara substituerade triazoler, deras framstaellning och kompositioner.
FI902686A0 (fi) Foerfarande foer framstaellning av dubbelsidigt belagda bandtransportoerer, i synnerhet foer pappers- och textilmaskiner, och anordning foer utfoering av foerfarandet.
FI890098A (fi) Pyrazol- och indazolpyridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI902852A0 (fi) Renininhibitoriska peptider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI900682A0 (fi) Verktyg, paosaettningsmedel och ringanordning foer kedjor foer foerhindrande av glidning.
FI902199A0 (fi) 5-substituerade 3-aryl-isoxazolderivat, deras framstaellning och deras anvaendning som skadedjursbekaempningsmedel.
FI891409A0 (fi) Dietylenglykolmonoestrar, foerfaranden foer deras framstaellning och deras framstaellning och deras anvaendning som laekemedel.
FI905753A (fi) Biologiskt nedbrytbara, vattenloesliga polykarboxylsyrakopolymerer, kompositioner innehaollande dylika kopolymerer, och foerfaranden foer anvaendning av saodana polymerer.
FI902177A0 (fi) Kompositioner som innehaoller elastomerer och icke-karboniserade, metaller innehaollande komplex.
FI900102A (fi) 7-aryl- ochheteroaryletrar av desacetylforskolin, foerfrande foer deras framstaellning och deras anvaending som laekemedel.
FI895997A0 (fi) Vaeggkonstruktion, saett och anordning foer bearbetning av vaeggstockar.
FI914557A (fi) 4- eller 5-substituerade pyridiner-2 karboxylsyror, foerfarande foer deras frmstaellning och deras anvaendning som laekemedel.
FI901295A0 (fi) 2-halogencyklopropanderivat, foerfarande foer deras framstaellning och deras anvaendning som skadedjursutrotningsmedel.
FI904417A0 (fi) 2-fluorcyklopropylaettikasyraestrar, foerfaranden foer deras framstaellning och deras anvaendning som pesticider.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT